Vanguard Total Stock Market ETF (VTI)

Shares of both companies tumbled about 15% on Wednesday at the time of writing.

Tesla recorded a 9.3% increase in wholesale sales in January, according to a report by CNEVPost.

Texas Instruments said that it will acquire Silicon Labs for $231.00 per share in an all-cash transaction, representing a total enterprise value of approximately $7.5 billion.

In a chat with Reliance Industries CEO Mukesh Ambani, organized by Moneycontrol, Fink stated that it is necessary to rapidly expand AI opportunities.

Prelude Therapeutics said on Tuesday that the FDA gave clearances to proceed with early-stage trials for its experimental drug PRT12396.

Intel CEO Lip-Bu Tan said at the Cisco AI Summit on Tuesday that the company has appointed a new chief architect for the graphics processing units.

Gary Black, managing partner of Future Fund, said in a post on X that PayPal’s limitation is that it is very expensive for sellers compared to other online payment providers.

Late on Monday, the company launched a new Model Y variant in the U.S., called the Model Y AWD for $41,990, and renamed the cheaper Model Y Standard to Model Y RWD.

According to a Bloomberg report, the proposal aims to encourage home builders to construct homes under a plan that would allow people to transition from renting to owning.

Marvell announced the completion of its acquisition of startup Celestial AI on Monday.

The company announced that a strategic investor would invest 15,000 bitcoins in exchange for a significant equity stake in the insurance firm.

According to TheFly, KeyBanc reduced its price target for The Trade Desk to $40 from $88, while maintaining its ‘Overweight’ rating on the shares.

Baird upgraded Palantir to ‘Outperform’ from ‘Neutral’ while keeping its $200 price target unchanged.

SOFI shares traded up over 4% in pre-market on Tuesday after a relentless sell-off that lasted for seven straight sessions.

Jackson said he is “long” Palantir, pointing to the analytics company’s results as evidence of a marked shift in how easily it is now winning business.

The company projected its Q1 2026 revenue below analyst estimates, according to data from fiscal.ai.

It's more important than ever to ensure you're investing in the right places.

Atossa Therapeutics said last week that its board has approved a reverse stock split of the company’s common stock, at a ratio of 15:1, with an effective time of 12:01 a.m. Eastern Time on February 2, 2026.